Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Anushka Mukherjee

Edwards Lifesciences Stock: Is EW Outperforming the Healthcare Sector?

Valued at approximately $47.8 billion by market capitalization, California-based Edwards Lifesciences Corporation (EW) develops products and technologies to treat advanced cardiovascular diseases across the United States, Europe, Japan, and other international markets. Companies with valuations of $10 billion or more are generally classified as “large-cap” stocks, and Edwards Lifesciences comfortably fits into this category.

As the world’s leading structural heart innovation company, Edwards Lifesciences is driven by its mission to improve patient outcomes. Through breakthrough technologies, robust clinical evidence, and close collaboration with clinicians and healthcare partners, the company continues to deliver meaningful advances in cardiovascular care, guided by a strong patient-centered culture.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.